

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to zinc ion (GO:0071294) | 8.21271186 |
| 2 | hemidesmosome assembly (GO:0031581) | 6.22782472 |
| 3 | cellular response to cadmium ion (GO:0071276) | 6.02118374 |
| 4 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58519382 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.48038547 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.48038547 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.42945365 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 5.42945365 |
| 9 | regulation of sequestering of triglyceride (GO:0010889) | 5.41701468 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.35397275 |
| 11 | low-density lipoprotein particle clearance (GO:0034383) | 5.22396951 |
| 12 | regulation of triglyceride catabolic process (GO:0010896) | 5.10643770 |
| 13 | complement activation, alternative pathway (GO:0006957) | 4.91344365 |
| 14 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.89198518 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 4.83459209 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 4.75051705 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.73825236 |
| 18 | valine metabolic process (GO:0006573) | 4.72111510 |
| 19 | fatty acid beta-oxidation (GO:0006635) | 4.69680172 |
| 20 | plasma lipoprotein particle clearance (GO:0034381) | 4.64002316 |
| 21 | triglyceride catabolic process (GO:0019433) | 4.62301475 |
| 22 | positive regulation of fatty acid oxidation (GO:0046321) | 4.51864572 |
| 23 | cysteine metabolic process (GO:0006534) | 4.48926085 |
| 24 | fatty acid oxidation (GO:0019395) | 4.41471182 |
| 25 | neutral lipid catabolic process (GO:0046461) | 4.41257932 |
| 26 | acylglycerol catabolic process (GO:0046464) | 4.41257932 |
| 27 | fatty acid transmembrane transport (GO:1902001) | 4.39962984 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.39873502 |
| 29 | glyoxylate metabolic process (GO:0046487) | 4.38245292 |
| 30 | lysine metabolic process (GO:0006553) | 4.37681353 |
| 31 | lysine catabolic process (GO:0006554) | 4.37681353 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.35323261 |
| 33 | lipid oxidation (GO:0034440) | 4.33854788 |
| 34 | urea cycle (GO:0000050) | 4.33257870 |
| 35 | urea metabolic process (GO:0019627) | 4.33257870 |
| 36 | bile acid biosynthetic process (GO:0006699) | 4.32969681 |
| 37 | biotin metabolic process (GO:0006768) | 4.32406475 |
| 38 | positive regulation of lipid catabolic process (GO:0050996) | 4.30148444 |
| 39 | protein carboxylation (GO:0018214) | 4.26129359 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.26129359 |
| 41 | fatty acid catabolic process (GO:0009062) | 4.25715066 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.21623763 |
| 43 | regulation of complement activation (GO:0030449) | 4.21338303 |
| 44 | * acylglycerol homeostasis (GO:0055090) | 4.21080391 |
| 45 | * triglyceride homeostasis (GO:0070328) | 4.21080391 |
| 46 | peptidyl-proline hydroxylation (GO:0019511) | 4.16459047 |
| 47 | acetyl-CoA metabolic process (GO:0006084) | 4.15955005 |
| 48 | indole-containing compound catabolic process (GO:0042436) | 4.12171704 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 4.12171704 |
| 50 | tryptophan catabolic process (GO:0006569) | 4.12171704 |
| 51 | kynurenine metabolic process (GO:0070189) | 4.11355817 |
| 52 | regulation of fibrinolysis (GO:0051917) | 4.09490888 |
| 53 | high-density lipoprotein particle remodeling (GO:0034375) | 4.09064479 |
| 54 | nitrogen cycle metabolic process (GO:0071941) | 4.00734223 |
| 55 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.98886868 |
| 56 | serine family amino acid catabolic process (GO:0009071) | 3.98580920 |
| 57 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.96506689 |
| 58 | tryptophan metabolic process (GO:0006568) | 3.89702652 |
| 59 | homocysteine metabolic process (GO:0050667) | 3.88918964 |
| 60 | bile acid metabolic process (GO:0008206) | 3.86714158 |
| 61 | monocarboxylic acid catabolic process (GO:0072329) | 3.86182864 |
| 62 | protein hydroxylation (GO:0018126) | 3.85808531 |
| 63 | reverse cholesterol transport (GO:0043691) | 3.84029474 |
| 64 | regulation of cholesterol storage (GO:0010885) | 3.83170748 |
| 65 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.82799716 |
| 66 | carnitine shuttle (GO:0006853) | 3.82647329 |
| 67 | cell adhesion mediated by integrin (GO:0033627) | 3.82424362 |
| 68 | regulation of fatty acid oxidation (GO:0046320) | 3.81318604 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 3.80811865 |
| 70 | macromolecular complex remodeling (GO:0034367) | 3.80811865 |
| 71 | plasma lipoprotein particle remodeling (GO:0034369) | 3.80811865 |
| 72 | regulation of metalloenzyme activity (GO:0048552) | 3.80553915 |
| 73 | branched-chain amino acid catabolic process (GO:0009083) | 3.73021943 |
| 74 | epoxygenase P450 pathway (GO:0019373) | 3.69814607 |
| 75 | desmosome organization (GO:0002934) | 3.69695403 |
| 76 | carnitine metabolic process (GO:0009437) | 3.67120229 |
| 77 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.66902123 |
| 78 | 2-oxoglutarate metabolic process (GO:0006103) | 3.66131559 |
| 79 | brown fat cell differentiation (GO:0050873) | 3.65660850 |
| 80 | endodermal cell differentiation (GO:0035987) | 3.65561916 |
| 81 | cell-substrate junction assembly (GO:0007044) | 3.63595498 |
| 82 | branched-chain amino acid metabolic process (GO:0009081) | 3.61798980 |
| 83 | short-chain fatty acid metabolic process (GO:0046459) | 3.61189829 |
| 84 | regulation of cholesterol esterification (GO:0010872) | 3.60998292 |
| 85 | alpha-amino acid catabolic process (GO:1901606) | 3.60648798 |
| 86 | lung vasculature development (GO:0060426) | 3.60049327 |
| 87 | ethanol oxidation (GO:0006069) | 3.59755078 |
| 88 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.57007499 |
| 89 | skin morphogenesis (GO:0043589) | 3.55561512 |
| 90 | regulation of triglyceride metabolic process (GO:0090207) | 3.55344126 |
| 91 | tyrosine metabolic process (GO:0006570) | 3.52533818 |
| 92 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.48681904 |
| 93 | organic acid catabolic process (GO:0016054) | 3.46791013 |
| 94 | carboxylic acid catabolic process (GO:0046395) | 3.46791013 |
| 95 | regulation of gonadotropin secretion (GO:0032276) | 3.46722586 |
| 96 | phospholipid homeostasis (GO:0055091) | 3.45957612 |
| 97 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.45760112 |
| 98 | aromatic amino acid family metabolic process (GO:0009072) | 3.45345775 |
| 99 | cellular amino acid catabolic process (GO:0009063) | 3.44711831 |
| 100 | triglyceride metabolic process (GO:0006641) | 3.44264039 |
| 101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.43742109 |
| 102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.43742109 |
| 103 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.42329047 |
| 104 | phospholipid efflux (GO:0033700) | 3.42026767 |
| 105 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.41170090 |
| 106 | positive regulation of lipid storage (GO:0010884) | 3.40231705 |
| 107 | 4-hydroxyproline metabolic process (GO:0019471) | 3.35574092 |
| 108 | regulation of cholesterol metabolic process (GO:0090181) | 3.31516780 |
| 109 | coenzyme catabolic process (GO:0009109) | 3.29584319 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 3.28470067 |
| 111 | cholesterol homeostasis (GO:0042632) | 3.28416334 |
| 112 | acyl-CoA biosynthetic process (GO:0071616) | 3.27418238 |
| 113 | thioester biosynthetic process (GO:0035384) | 3.27418238 |
| 114 | cellular ketone body metabolic process (GO:0046950) | 3.27321915 |
| 115 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.26963792 |
| 116 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.25468812 |
| 117 | sterol homeostasis (GO:0055092) | 3.24832616 |
| 118 | acylglycerol metabolic process (GO:0006639) | 3.24092097 |
| 119 | fibrinolysis (GO:0042730) | 3.23119835 |
| 120 | cytolysis (GO:0019835) | 3.22698882 |
| 121 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.19882138 |
| 122 | positive regulation of calcium ion import (GO:0090280) | 3.10957621 |
| 123 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.10930404 |
| 124 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.10624450 |
| 125 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.09837008 |
| 126 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.08941827 |
| 127 | lipid storage (GO:0019915) | 3.06479553 |
| 128 | positive regulation of protein kinase C signaling (GO:0090037) | 3.06293182 |
| 129 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.03161281 |
| 130 | response to zinc ion (GO:0010043) | 2.94153127 |
| 131 | cell migration involved in heart development (GO:0060973) | 2.92805772 |
| 132 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.92525638 |
| 133 | endocrine hormone secretion (GO:0060986) | 2.92434794 |
| 134 | regulation of plasminogen activation (GO:0010755) | 2.92020562 |
| 135 | chondrocyte proliferation (GO:0035988) | 2.89132593 |
| 136 | positive regulation of p38MAPK cascade (GO:1900745) | 2.88988274 |
| 137 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.88258718 |
| 138 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.86518530 |
| 139 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.82080756 |
| 140 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.81013220 |
| 141 | endothelium development (GO:0003158) | 2.80346624 |
| 142 | positive regulation of fat cell differentiation (GO:0045600) | 2.77295352 |
| 143 | cellular copper ion homeostasis (GO:0006878) | 2.75485304 |
| 144 | regulation of vitamin metabolic process (GO:0030656) | 2.75341454 |
| 145 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.74762915 |
| 146 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.74487458 |
| 147 | negative regulation of protein autophosphorylation (GO:0031953) | 2.71604207 |
| 148 | type B pancreatic cell proliferation (GO:0044342) | 2.69727340 |
| 149 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.69253586 |
| 150 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.66835586 |
| 151 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.66025313 |
| 152 | positive regulation of positive chemotaxis (GO:0050927) | 2.63182044 |
| 153 | response to cadmium ion (GO:0046686) | 2.61051677 |
| 154 | lymphangiogenesis (GO:0001946) | 2.60825423 |
| 155 | wound healing, spreading of epidermal cells (GO:0035313) | 2.59234318 |
| 156 | regulation of positive chemotaxis (GO:0050926) | 2.58230266 |
| 157 | decidualization (GO:0046697) | 2.55080285 |
| 158 | regulation of monocyte chemotaxis (GO:0090025) | 2.55002964 |
| 159 | positive regulation of metanephros development (GO:0072216) | 2.53951058 |
| 160 | keratinocyte proliferation (GO:0043616) | 2.50225857 |
| 161 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.50093701 |
| 162 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.50043742 |
| 163 | endothelial cell chemotaxis (GO:0035767) | 2.48789318 |
| 164 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.47654635 |
| 165 | protein localization to endosome (GO:0036010) | 2.47375952 |
| 166 | positive regulation of extracellular matrix organization (GO:1903055) | 2.46769785 |
| 167 | L-serine transport (GO:0015825) | 2.46196658 |
| 168 | serine transport (GO:0032329) | 2.45631492 |
| 169 | virion attachment to host cell (GO:0019062) | 2.41269651 |
| 170 | adhesion of symbiont to host cell (GO:0044650) | 2.41269651 |
| 171 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.40528474 |
| 172 | negative regulation of anoikis (GO:2000811) | 2.40430443 |
| 173 | barbed-end actin filament capping (GO:0051016) | 2.39774463 |
| 174 | COPII vesicle coating (GO:0048208) | 2.39305129 |
| 175 | regulation of lipid storage (GO:0010883) | 2.38328195 |
| 176 | protein heterotrimerization (GO:0070208) | 2.34374143 |
| 177 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.33545751 |
| 178 | glucocorticoid biosynthetic process (GO:0006704) | 2.31579420 |
| 179 | regulation of p38MAPK cascade (GO:1900744) | 2.30329926 |
| 180 | adhesion of symbiont to host (GO:0044406) | 2.30032908 |
| 181 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.29553564 |
| 182 | cAMP biosynthetic process (GO:0006171) | 2.29140324 |
| 183 | negative regulation of viral entry into host cell (GO:0046597) | 2.28630415 |
| 184 | positive regulation of astrocyte differentiation (GO:0048711) | 2.28512295 |
| 185 | extracellular matrix assembly (GO:0085029) | 2.27501697 |
| 186 | regulation of protein kinase C signaling (GO:0090036) | 2.27191890 |
| 187 | regulation of smooth muscle cell migration (GO:0014910) | 2.25129377 |
| 188 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.24349047 |
| 189 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.24201862 |
| 190 | progesterone metabolic process (GO:0042448) | 2.23991189 |
| 191 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.23757796 |
| 192 | negative regulation of lipid storage (GO:0010888) | 2.23253870 |
| 193 | hyaluronan catabolic process (GO:0030214) | 2.22610287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.72313254 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.45700087 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.83702557 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.94178291 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.36425474 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.75055101 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.49064911 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.29781450 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.91759144 |
| 10 | * CLOCK_20551151_ChIP-Seq_293T_Human | 3.52616053 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.43306590 |
| 12 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.91179634 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.87747110 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.25316103 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.23989828 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88587812 |
| 17 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.88366472 |
| 18 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.88366472 |
| 19 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.76606864 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.75508576 |
| 21 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73576466 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.72386703 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71443959 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67182755 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.62615719 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62573164 |
| 27 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.54145270 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.52938078 |
| 29 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.52694437 |
| 30 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.50289207 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.45898459 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42956170 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36524072 |
| 34 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.34547801 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31423821 |
| 36 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.29408613 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25554387 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22970733 |
| 39 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.22577309 |
| 40 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.21989653 |
| 41 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21977221 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18236676 |
| 43 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17384513 |
| 44 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17013824 |
| 45 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12605749 |
| 46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11135626 |
| 47 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09606509 |
| 48 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09083352 |
| 49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07940427 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.05830842 |
| 51 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.05210978 |
| 52 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02970482 |
| 53 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02760633 |
| 54 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.02077844 |
| 55 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00530182 |
| 56 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00319883 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99221506 |
| 58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98703567 |
| 59 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98069876 |
| 60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96527167 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95990726 |
| 62 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.95586120 |
| 63 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.93749757 |
| 64 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93082510 |
| 65 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.92179316 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91720497 |
| 67 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91523526 |
| 68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91032463 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90307381 |
| 70 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.90179313 |
| 71 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89519194 |
| 72 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89315097 |
| 73 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88401777 |
| 74 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88112539 |
| 75 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87126381 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87103620 |
| 77 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85968619 |
| 78 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85518908 |
| 79 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.85360698 |
| 80 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.84894395 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83848403 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83010379 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82731403 |
| 84 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.82007439 |
| 85 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81552694 |
| 86 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81480588 |
| 87 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80584230 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80364204 |
| 89 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80147770 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.78854559 |
| 91 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77701257 |
| 92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77686546 |
| 93 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77683995 |
| 94 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77683995 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77618568 |
| 96 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76757674 |
| 97 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.75779256 |
| 98 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.75570785 |
| 99 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.74380066 |
| 100 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.70615605 |
| 101 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.70170305 |
| 102 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.69772112 |
| 103 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.68125215 |
| 104 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.65337000 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64757232 |
| 106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64757232 |
| 107 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.64596392 |
| 108 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64507215 |
| 109 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.64295169 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.62526660 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61889877 |
| 112 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61797136 |
| 113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59858931 |
| 114 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.59353701 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.59311683 |
| 116 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.58465908 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58097632 |
| 118 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.56160243 |
| 119 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.55838741 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55732555 |
| 121 | CJUN_26792858_Chip-Seq_BT549_Human | 0.55360494 |
| 122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.55169599 |
| 123 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.54253972 |
| 124 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.54099070 |
| 125 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.53130410 |
| 126 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.52896340 |
| 127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.51658572 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51521855 |
| 129 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.51385753 |
| 130 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.51184808 |
| 131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.51125661 |
| 132 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.49389807 |
| 133 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.49115384 |
| 134 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.48729343 |
| 135 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48646954 |
| 136 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.48506308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.89308378 |
| 2 | MP0005360_urolithiasis | 5.54073442 |
| 3 | MP0005365_abnormal_bile_salt | 4.71123870 |
| 4 | MP0005670_abnormal_white_adipose | 4.58502884 |
| 5 | MP0003950_abnormal_plasma_membrane | 4.58001584 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 4.32419438 |
| 7 | * MP0010329_abnormal_lipoprotein_level | 3.58254459 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.40707080 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.87489017 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.82854346 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.76718890 |
| 12 | MP0004130_abnormal_muscle_cell | 2.74580276 |
| 13 | MP0003252_abnormal_bile_duct | 2.66745355 |
| 14 | * MP0005666_abnormal_adipose_tissue | 2.59376484 |
| 15 | MP0009840_abnormal_foam_cell | 2.51388298 |
| 16 | MP0005332_abnormal_amino_acid | 2.41784638 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 2.38423669 |
| 18 | * MP0002118_abnormal_lipid_homeostasis | 2.28418375 |
| 19 | MP0000609_abnormal_liver_physiology | 2.21365102 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.09972422 |
| 21 | MP0002971_abnormal_brown_adipose | 2.04872427 |
| 22 | MP0003453_abnormal_keratinocyte_physiol | 1.93783778 |
| 23 | MP0003091_abnormal_cell_migration | 1.89306181 |
| 24 | MP0004510_myositis | 1.87720834 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.84712648 |
| 26 | * MP0005375_adipose_tissue_phenotype | 1.84435414 |
| 27 | MP0003195_calcinosis | 1.81701680 |
| 28 | MP0005083_abnormal_biliary_tract | 1.80751513 |
| 29 | MP0003724_increased_susceptibility_to | 1.76897308 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.75734567 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.74961977 |
| 32 | MP0003011_delayed_dark_adaptation | 1.74224149 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.73358679 |
| 34 | MP0003186_abnormal_redox_activity | 1.72205568 |
| 35 | MP0005275_abnormal_skin_tensile | 1.68529558 |
| 36 | MP0005623_abnormal_meninges_morphology | 1.60285090 |
| 37 | MP0009115_abnormal_fat_cell | 1.59266307 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.54950285 |
| 39 | MP0000762_abnormal_tongue_morphology | 1.54717002 |
| 40 | MP0002254_reproductive_system_inflammat | 1.52470012 |
| 41 | MP0005334_abnormal_fat_pad | 1.51037250 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.45671600 |
| 43 | MP0000579_abnormal_nail_morphology | 1.43656468 |
| 44 | MP0001958_emphysema | 1.42208418 |
| 45 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.41354651 |
| 46 | MP0000767_abnormal_smooth_muscle | 1.41077031 |
| 47 | MP0001661_extended_life_span | 1.37794096 |
| 48 | MP0001764_abnormal_homeostasis | 1.34789438 |
| 49 | MP0005503_abnormal_tendon_morphology | 1.33217968 |
| 50 | MP0000003_abnormal_adipose_tissue | 1.32727421 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.32531870 |
| 52 | MP0010030_abnormal_orbit_morphology | 1.32456203 |
| 53 | MP0002933_joint_inflammation | 1.29413798 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.26666981 |
| 55 | MP0008260_abnormal_autophagy | 1.26482322 |
| 56 | MP0004272_abnormal_basement_membrane | 1.25947414 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.25403068 |
| 58 | MP0002970_abnormal_white_adipose | 1.25207072 |
| 59 | MP0003075_altered_response_to | 1.25171092 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.25138695 |
| 61 | MP0001216_abnormal_epidermal_layer | 1.24977241 |
| 62 | MP0001881_abnormal_mammary_gland | 1.22329777 |
| 63 | MP0005409_darkened_coat_color | 1.20043076 |
| 64 | MP0009053_abnormal_anal_canal | 1.19061911 |
| 65 | MP0000467_abnormal_esophagus_morphology | 1.16766706 |
| 66 | MP0005165_increased_susceptibility_to | 1.15112581 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 1.14811544 |
| 68 | MP0000598_abnormal_liver_morphology | 1.13923949 |
| 69 | MP0005535_abnormal_body_temperature | 1.11705519 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 1.10385651 |
| 71 | MP0001542_abnormal_bone_strength | 1.09015931 |
| 72 | MP0001849_ear_inflammation | 1.04508902 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 1.01189275 |
| 74 | MP0003690_abnormal_glial_cell | 1.00303523 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 1.00110506 |
| 76 | * MP0009763_increased_sensitivity_to | 0.99110684 |
| 77 | MP0004947_skin_inflammation | 0.98780756 |
| 78 | MP0001915_intracranial_hemorrhage | 0.97817012 |
| 79 | MP0008775_abnormal_heart_ventricle | 0.96046956 |
| 80 | MP0003303_peritoneal_inflammation | 0.95303159 |
| 81 | MP0002060_abnormal_skin_morphology | 0.94951877 |
| 82 | MP0003941_abnormal_skin_development | 0.94619891 |
| 83 | MP0004233_abnormal_muscle_weight | 0.94531094 |
| 84 | MP0009764_decreased_sensitivity_to | 0.92431194 |
| 85 | MP0009278_abnormal_bone_marrow | 0.92411075 |
| 86 | MP0004858_abnormal_nervous_system | 0.88572177 |
| 87 | MP0005448_abnormal_energy_balance | 0.88412539 |
| 88 | MP0010771_integument_phenotype | 0.88108684 |
| 89 | MP0001756_abnormal_urination | 0.87502569 |
| 90 | MP0003868_abnormal_feces_composition | 0.87455634 |
| 91 | MP0005410_abnormal_fertilization | 0.86325266 |
| 92 | MP0000858_altered_metastatic_potential | 0.85974189 |
| 93 | MP0005257_abnormal_intraocular_pressure | 0.85417842 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 0.85246030 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.85246030 |
| 96 | MP0005508_abnormal_skeleton_morphology | 0.83849923 |
| 97 | MP0001501_abnormal_sleep_pattern | 0.83358797 |
| 98 | MP0009780_abnormal_chondrocyte_physiolo | 0.83029066 |
| 99 | MP0005501_abnormal_skin_physiology | 0.82804526 |
| 100 | MP0003959_abnormal_lean_body | 0.81982383 |
| 101 | MP0005647_abnormal_sex_gland | 0.81902528 |
| 102 | MP0002796_impaired_skin_barrier | 0.81689768 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.78979276 |
| 104 | MP0008469_abnormal_protein_level | 0.78182204 |
| 105 | MP0009697_abnormal_copulation | 0.78040284 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.77431548 |
| 107 | MP0005164_abnormal_response_to | 0.76999104 |
| 108 | MP0005166_decreased_susceptibility_to | 0.76263192 |
| 109 | MP0003300_gastrointestinal_ulcer | 0.75440801 |
| 110 | MP0005451_abnormal_body_composition | 0.75249844 |
| 111 | MP0002998_abnormal_bone_remodeling | 0.74638514 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.74306674 |
| 113 | MP0000604_amyloidosis | 0.73452144 |
| 114 | * MP0009642_abnormal_blood_homeostasis | 0.73317820 |
| 115 | MP0003828_pulmonary_edema | 0.73076041 |
| 116 | MP0003448_altered_tumor_morphology | 0.72817649 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.72804987 |
| 118 | MP0009931_abnormal_skin_appearance | 0.70832469 |
| 119 | MP0000749_muscle_degeneration | 0.69843674 |
| 120 | MP0000750_abnormal_muscle_regeneration | 0.68480944 |
| 121 | MP0005636_abnormal_mineral_homeostasis | 0.68095193 |
| 122 | MP0000343_altered_response_to | 0.67820038 |
| 123 | MP0005023_abnormal_wound_healing | 0.66784518 |
| 124 | MP0006054_spinal_hemorrhage | 0.66070384 |
| 125 | MP0010678_abnormal_skin_adnexa | 0.65892624 |
| 126 | MP0000249_abnormal_blood_vessel | 0.65670944 |
| 127 | MP0006138_congestive_heart_failure | 0.65555033 |
| 128 | MP0001614_abnormal_blood_vessel | 0.65332757 |
| 129 | MP0002896_abnormal_bone_mineralization | 0.65228011 |
| 130 | MP0001851_eye_inflammation | 0.63449173 |
| 131 | MP0002168_other_aberrant_phenotype | 0.62992745 |
| 132 | MP0004147_increased_porphyrin_level | 0.62721038 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.62242739 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.59854857 |
| 135 | MP0003279_aneurysm | 0.59224186 |
| 136 | MP0001853_heart_inflammation | 0.58399361 |
| 137 | MP0002295_abnormal_pulmonary_circulatio | 0.57400446 |
| 138 | MP0005266_abnormal_metabolism | 0.57240721 |
| 139 | MP0005167_abnormal_blood-brain_barrier | 0.57231287 |
| 140 | * MP0005452_abnormal_adipose_tissue | 0.57018230 |
| 141 | MP0001243_abnormal_dermal_layer | 0.56560409 |
| 142 | MP0009765_abnormal_xenobiotic_induced | 0.56131346 |
| 143 | * MP0001879_abnormal_lymphatic_vessel | 0.55904442 |
| 144 | MP0005330_cardiomyopathy | 0.52056092 |
| 145 | MP0005595_abnormal_vascular_smooth | 0.50387371 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.49179832 |
| 147 | MP0001544_abnormal_cardiovascular_syste | 0.48524588 |
| 148 | MP0005385_cardiovascular_system_phenoty | 0.48524588 |
| 149 | MP0005058_abnormal_lysosome_morphology | 0.47969393 |
| 150 | MP0003953_abnormal_hormone_level | 0.47670655 |
| 151 | MP0005395_other_phenotype | 0.47496217 |
| 152 | MP0005084_abnormal_gallbladder_morpholo | 0.46930124 |
| 153 | MP0004883_abnormal_blood_vessel | 0.46774348 |
| 154 | MP0001533_abnormal_skeleton_physiology | 0.46772557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Xanthomatosis (HP:0000991) | 5.61285084 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.60962186 |
| 3 | Hyperglycinuria (HP:0003108) | 5.23751804 |
| 4 | Atrophic scars (HP:0001075) | 5.13844234 |
| 5 | Complement deficiency (HP:0004431) | 5.08241541 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.01454629 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 4.88851535 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.86031685 |
| 9 | Abnormality of glycine metabolism (HP:0010895) | 4.67690502 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.67690502 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.57578043 |
| 12 | Hyperammonemia (HP:0001987) | 4.51489111 |
| 13 | Hypoglycemic coma (HP:0001325) | 4.44923144 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 4.43370193 |
| 15 | Prolonged partial thromboplastin time (HP:0003645) | 4.34593501 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 4.33740387 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.24470892 |
| 18 | Milia (HP:0001056) | 4.20078263 |
| 19 | Hyperglycinemia (HP:0002154) | 4.19123442 |
| 20 | Epidermoid cyst (HP:0200040) | 4.18247641 |
| 21 | Hypolipoproteinemia (HP:0010981) | 4.16547552 |
| 22 | Axonal loss (HP:0003447) | 4.11788531 |
| 23 | Cervical subluxation (HP:0003308) | 4.11566557 |
| 24 | Ketosis (HP:0001946) | 4.09262817 |
| 25 | Follicular hyperkeratosis (HP:0007502) | 4.07627789 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.07082436 |
| 27 | Onycholysis (HP:0001806) | 3.98942369 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.85767003 |
| 29 | Plantar hyperkeratosis (HP:0007556) | 3.83760342 |
| 30 | Abnormality of complement system (HP:0005339) | 3.79492717 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.79337057 |
| 32 | Fragile nails (HP:0001808) | 3.71572597 |
| 33 | Thick nail (HP:0001805) | 3.65720717 |
| 34 | Abnormality of nail color (HP:0100643) | 3.62051112 |
| 35 | Hypertriglyceridemia (HP:0002155) | 3.49810436 |
| 36 | Alopecia of scalp (HP:0002293) | 3.42267283 |
| 37 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.37322661 |
| 38 | Dicarboxylic aciduria (HP:0003215) | 3.37322661 |
| 39 | Joint hemorrhage (HP:0005261) | 3.35172446 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 3.30786156 |
| 41 | Myocardial infarction (HP:0001658) | 3.29234280 |
| 42 | Hypercholesterolemia (HP:0003124) | 3.25872883 |
| 43 | Ketoacidosis (HP:0001993) | 3.24310381 |
| 44 | Vascular tortuosity (HP:0004948) | 3.23361989 |
| 45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.15915264 |
| 46 | Arterial tortuosity (HP:0005116) | 3.15347913 |
| 47 | Oligomenorrhea (HP:0000876) | 3.13822586 |
| 48 | Nail dystrophy (HP:0008404) | 3.10644849 |
| 49 | Acanthosis nigricans (HP:0000956) | 3.06131314 |
| 50 | Fragile skin (HP:0001030) | 3.04554789 |
| 51 | Hydroxyprolinuria (HP:0003080) | 3.00898655 |
| 52 | Abnormality of proline metabolism (HP:0010907) | 3.00898655 |
| 53 | Palmoplantar hyperkeratosis (HP:0000972) | 3.00165754 |
| 54 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.96923676 |
| 55 | Abnormality of the intrinsic pathway (HP:0010989) | 2.94661578 |
| 56 | Skin nodule (HP:0200036) | 2.92919382 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 2.86662375 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.83715102 |
| 59 | Abnormality of methionine metabolism (HP:0010901) | 2.79443519 |
| 60 | Vertebral compression fractures (HP:0002953) | 2.74877515 |
| 61 | Palmar hyperkeratosis (HP:0010765) | 2.74616406 |
| 62 | Nausea (HP:0002018) | 2.72888405 |
| 63 | Blue sclerae (HP:0000592) | 2.72683950 |
| 64 | Fat malabsorption (HP:0002630) | 2.66510648 |
| 65 | Abnormal cartilage morphology (HP:0002763) | 2.65434863 |
| 66 | Generalized aminoaciduria (HP:0002909) | 2.64927554 |
| 67 | Abnormality of nucleobase metabolism (HP:0010932) | 2.63380786 |
| 68 | Myoglobinuria (HP:0002913) | 2.62957199 |
| 69 | Lethargy (HP:0001254) | 2.61278893 |
| 70 | Nuclear cataract (HP:0100018) | 2.60643047 |
| 71 | Spinal rigidity (HP:0003306) | 2.52182588 |
| 72 | Metabolic acidosis (HP:0001942) | 2.51430297 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 2.49860767 |
| 74 | Short nail (HP:0001799) | 2.49546919 |
| 75 | Abnormality of the costochondral junction (HP:0000919) | 2.46929009 |
| 76 | Hemorrhage of the eye (HP:0011885) | 2.46398038 |
| 77 | Right ventricular cardiomyopathy (HP:0011663) | 2.43335734 |
| 78 | Aortic dissection (HP:0002647) | 2.42821699 |
| 79 | Hepatocellular carcinoma (HP:0001402) | 2.42397378 |
| 80 | Ankle contracture (HP:0006466) | 2.41247635 |
| 81 | Wormian bones (HP:0002645) | 2.40759700 |
| 82 | Rhabdomyolysis (HP:0003201) | 2.40359037 |
| 83 | Pancreatitis (HP:0001733) | 2.38473059 |
| 84 | Delayed CNS myelination (HP:0002188) | 2.38154452 |
| 85 | Corneal dystrophy (HP:0001131) | 2.37723289 |
| 86 | Amyloidosis (HP:0011034) | 2.32127314 |
| 87 | Esophageal varix (HP:0002040) | 2.31245955 |
| 88 | Abnormality of glycolipid metabolism (HP:0010969) | 2.31203463 |
| 89 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.31203463 |
| 90 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.31203463 |
| 91 | Hyperbilirubinemia (HP:0002904) | 2.29659378 |
| 92 | Soft skin (HP:0000977) | 2.29399857 |
| 93 | Recurrent corneal erosions (HP:0000495) | 2.29177084 |
| 94 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.22712155 |
| 95 | Spastic diplegia (HP:0001264) | 2.22424401 |
| 96 | Vomiting (HP:0002013) | 2.19753721 |
| 97 | Natal tooth (HP:0000695) | 2.18624358 |
| 98 | Cerebral edema (HP:0002181) | 2.18038362 |
| 99 | Insulin resistance (HP:0000855) | 2.16788427 |
| 100 | Spinal cord compression (HP:0002176) | 2.15188242 |
| 101 | Abnormal blistering of the skin (HP:0008066) | 2.15003636 |
| 102 | Gout (HP:0001997) | 2.14390218 |
| 103 | Cholecystitis (HP:0001082) | 2.14337032 |
| 104 | Abnormal gallbladder physiology (HP:0012438) | 2.14337032 |
| 105 | Increased muscle lipid content (HP:0009058) | 2.09370328 |
| 106 | Cardiovascular calcification (HP:0011915) | 2.08442197 |
| 107 | Protrusio acetabuli (HP:0003179) | 2.07848549 |
| 108 | Proximal tubulopathy (HP:0000114) | 2.07800613 |
| 109 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.07226651 |
| 110 | Nonimmune hydrops fetalis (HP:0001790) | 2.06459886 |
| 111 | Vascular calcification (HP:0004934) | 2.06392611 |
| 112 | Hypoglycemic seizures (HP:0002173) | 2.06272417 |
| 113 | Increased purine levels (HP:0004368) | 2.06230679 |
| 114 | Hyperuricemia (HP:0002149) | 2.06230679 |
| 115 | Mitral stenosis (HP:0001718) | 2.04791687 |
| 116 | Renal duplication (HP:0000075) | 2.02455601 |
| 117 | Type 1 muscle fiber predominance (HP:0003803) | 2.02193295 |
| 118 | Brushfield spots (HP:0001088) | 2.02131328 |
| 119 | Multiple enchondromatosis (HP:0005701) | 2.01827807 |
| 120 | Pigmentary retinal degeneration (HP:0001146) | 2.01453137 |
| 121 | Premature rupture of membranes (HP:0001788) | 2.00810794 |
| 122 | Increased serum pyruvate (HP:0003542) | 1.99491730 |
| 123 | Cholelithiasis (HP:0001081) | 1.98888699 |
| 124 | Spontaneous abortion (HP:0005268) | 1.98094944 |
| 125 | Abnormality of glycolysis (HP:0004366) | 1.98058841 |
| 126 | Abnormality of carpal bone ossification (HP:0006257) | 1.97586706 |
| 127 | Increased connective tissue (HP:0009025) | 1.96735419 |
| 128 | Parakeratosis (HP:0001036) | 1.96296356 |
| 129 | Bladder diverticulum (HP:0000015) | 1.95618334 |
| 130 | Steatorrhea (HP:0002570) | 1.95109594 |
| 131 | Shallow orbits (HP:0000586) | 1.94688355 |
| 132 | Abnormal gallbladder morphology (HP:0012437) | 1.94634472 |
| 133 | Hyperglycemia (HP:0003074) | 1.94458683 |
| 134 | Generalized amyotrophy (HP:0003700) | 1.94245260 |
| 135 | Increased variability in muscle fiber diameter (HP:0003557) | 1.93540695 |
| 136 | Corneal erosion (HP:0200020) | 1.93070162 |
| 137 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91846967 |
| 138 | Renal cortical cysts (HP:0000803) | 1.91814504 |
| 139 | Asymmetric septal hypertrophy (HP:0001670) | 1.89760844 |
| 140 | Sensorimotor neuropathy (HP:0007141) | 1.86709879 |
| 141 | Bone cyst (HP:0012062) | 1.86209889 |
| 142 | Polycythemia (HP:0001901) | 1.85511209 |
| 143 | Tetraparesis (HP:0002273) | 1.83163793 |
| 144 | Elbow flexion contracture (HP:0002987) | 1.82928673 |
| 145 | Aortic valve stenosis (HP:0001650) | 1.82927696 |
| 146 | Neonatal onset (HP:0003623) | 1.82762218 |
| 147 | Peritonitis (HP:0002586) | 1.82645104 |
| 148 | Broad metatarsal (HP:0001783) | 1.82463391 |
| 149 | Neurofibrillary tangles (HP:0002185) | 1.82427301 |
| 150 | Nephritis (HP:0000123) | 1.81937807 |
| 151 | Malnutrition (HP:0004395) | 1.81346445 |
| 152 | Elevated hepatic transaminases (HP:0002910) | 1.80699290 |
| 153 | Irritability (HP:0000737) | 1.79715737 |
| 154 | Cerebral aneurysm (HP:0004944) | 1.79324890 |
| 155 | Metaphyseal dysplasia (HP:0100255) | 1.79188621 |
| 156 | Joint stiffness (HP:0001387) | 1.79045016 |
| 157 | Ridged nail (HP:0001807) | 1.78753276 |
| 158 | Abnormality of iron homeostasis (HP:0011031) | 1.78371290 |
| 159 | Delayed gross motor development (HP:0002194) | 1.78283763 |
| 160 | Glomerulonephritis (HP:0000099) | 1.77823201 |
| 161 | Hyperextensible skin (HP:0000974) | 1.77541799 |
| 162 | Amniotic constriction ring (HP:0009775) | 1.77109265 |
| 163 | Abnormality of placental membranes (HP:0011409) | 1.77109265 |
| 164 | Hypoplasia of dental enamel (HP:0006297) | 1.76945639 |
| 165 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.76733417 |
| 166 | Ectropion (HP:0000656) | 1.76681521 |
| 167 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.75288219 |
| 168 | Abnormality of dentin (HP:0010299) | 1.72768779 |
| 169 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.72661403 |
| 170 | Pulmonary artery stenosis (HP:0004415) | 1.72252822 |
| 171 | Muscle stiffness (HP:0003552) | 1.71762329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.68600802 |
| 2 | TRIB3 | 4.37226426 |
| 3 | ERN1 | 4.36433225 |
| 4 | SIK1 | 4.00705356 |
| 5 | KDR | 3.82561439 |
| 6 | ARAF | 3.72283274 |
| 7 | CAMK1D | 3.16313489 |
| 8 | FGFR4 | 3.02004409 |
| 9 | MOS | 2.79511873 |
| 10 | TIE1 | 2.56108772 |
| 11 | MAP3K13 | 2.41880637 |
| 12 | STK24 | 2.26016567 |
| 13 | TGFBR2 | 2.17760520 |
| 14 | PIM2 | 2.16710411 |
| 15 | MST1R | 2.15456572 |
| 16 | MAP3K9 | 2.15051553 |
| 17 | NTRK1 | 2.13405251 |
| 18 | TESK1 | 2.12110115 |
| 19 | PDK3 | 2.05356151 |
| 20 | PDK4 | 2.05356151 |
| 21 | PKN2 | 1.99347088 |
| 22 | CAMK1G | 1.96539086 |
| 23 | RIPK1 | 1.79719094 |
| 24 | LATS1 | 1.75094342 |
| 25 | NEK9 | 1.57995085 |
| 26 | INSRR | 1.57350074 |
| 27 | PRKAA2 | 1.49560360 |
| 28 | PDK2 | 1.46930551 |
| 29 | PDGFRA | 1.35813585 |
| 30 | FLT3 | 1.31425278 |
| 31 | MAPK11 | 1.25058815 |
| 32 | PTK6 | 1.23528291 |
| 33 | ERBB4 | 1.21968837 |
| 34 | JAK1 | 1.21440505 |
| 35 | CDK6 | 1.18237270 |
| 36 | ABL2 | 1.17243974 |
| 37 | FRK | 1.15401056 |
| 38 | EPHB2 | 1.06029336 |
| 39 | MAP3K3 | 1.05536772 |
| 40 | JAK2 | 1.05270510 |
| 41 | BRAF | 1.04049874 |
| 42 | MET | 1.03960594 |
| 43 | FGFR3 | 1.02050446 |
| 44 | TYK2 | 1.00149046 |
| 45 | MAP2K3 | 0.99329141 |
| 46 | EPHA2 | 0.97888008 |
| 47 | MAP4K2 | 0.97669019 |
| 48 | CLK1 | 0.96384149 |
| 49 | EPHB1 | 0.96076675 |
| 50 | CDK9 | 0.95735982 |
| 51 | GRK5 | 0.93789153 |
| 52 | EPHA3 | 0.93401502 |
| 53 | MAP2K1 | 0.92721655 |
| 54 | MYLK | 0.92083872 |
| 55 | PIK3CG | 0.89377805 |
| 56 | ADRBK1 | 0.88689489 |
| 57 | KSR2 | 0.87264814 |
| 58 | TAOK2 | 0.87163935 |
| 59 | FGFR2 | 0.87122653 |
| 60 | GRK7 | 0.86315954 |
| 61 | TBK1 | 0.79736807 |
| 62 | FER | 0.79246216 |
| 63 | LATS2 | 0.78366796 |
| 64 | STK38L | 0.76471824 |
| 65 | GSK3A | 0.74982757 |
| 66 | MAP3K12 | 0.73937654 |
| 67 | PRPF4B | 0.72784325 |
| 68 | LIMK1 | 0.72651181 |
| 69 | IRAK3 | 0.72518796 |
| 70 | TTN | 0.70285013 |
| 71 | CDK4 | 0.66141412 |
| 72 | MAP3K11 | 0.64296550 |
| 73 | CSK | 0.63958783 |
| 74 | MTOR | 0.63157592 |
| 75 | PHKG2 | 0.63134731 |
| 76 | PHKG1 | 0.63134731 |
| 77 | MAP3K10 | 0.62450311 |
| 78 | MAP2K4 | 0.62410857 |
| 79 | MAP3K6 | 0.60066811 |
| 80 | MAPK15 | 0.59968900 |
| 81 | MAPK12 | 0.59895935 |
| 82 | STK38 | 0.59638442 |
| 83 | PAK2 | 0.59543445 |
| 84 | TGFBR1 | 0.59187073 |
| 85 | PRKAA1 | 0.59181922 |
| 86 | DDR2 | 0.59171055 |
| 87 | IGF1R | 0.59070369 |
| 88 | RAF1 | 0.58739686 |
| 89 | JAK3 | 0.57980923 |
| 90 | LRRK2 | 0.57874042 |
| 91 | NME2 | 0.57574665 |
| 92 | MAP3K7 | 0.57117116 |
| 93 | MAPK4 | 0.57045929 |
| 94 | LMTK2 | 0.56973696 |
| 95 | PDPK1 | 0.56804520 |
| 96 | TRPM7 | 0.56459323 |
| 97 | PTK2 | 0.55990372 |
| 98 | CDC42BPA | 0.55984811 |
| 99 | DAPK3 | 0.55822262 |
| 100 | IKBKB | 0.54391802 |
| 101 | TAOK3 | 0.54144325 |
| 102 | BMX | 0.53784650 |
| 103 | GRK1 | 0.52713880 |
| 104 | PRKACG | 0.51165512 |
| 105 | MAP3K1 | 0.50233450 |
| 106 | MAPK7 | 0.47672871 |
| 107 | STK3 | 0.47576870 |
| 108 | PIK3CA | 0.46770207 |
| 109 | MAPKAPK3 | 0.45097484 |
| 110 | DAPK2 | 0.44908271 |
| 111 | AKT3 | 0.43925851 |
| 112 | PINK1 | 0.42832613 |
| 113 | FGFR1 | 0.40517477 |
| 114 | RET | 0.39954084 |
| 115 | MAP2K6 | 0.39824396 |
| 116 | MUSK | 0.39089435 |
| 117 | PRKG2 | 0.37969751 |
| 118 | ROCK1 | 0.37365491 |
| 119 | INSR | 0.36461746 |
| 120 | RPS6KA4 | 0.36381963 |
| 121 | PTK2B | 0.34999902 |
| 122 | PAK6 | 0.34771228 |
| 123 | ILK | 0.34767807 |
| 124 | KSR1 | 0.34036509 |
| 125 | PDGFRB | 0.33858241 |
| 126 | KIT | 0.33536638 |
| 127 | STK10 | 0.32016819 |
| 128 | PDK1 | 0.31618873 |
| 129 | PRKD2 | 0.31320663 |
| 130 | ZAP70 | 0.31299171 |
| 131 | CSF1R | 0.30673986 |
| 132 | PRKCH | 0.30527919 |
| 133 | PRKD1 | 0.29788198 |
| 134 | MAP2K2 | 0.29326954 |
| 135 | ROCK2 | 0.28838090 |
| 136 | PAK4 | 0.28246253 |
| 137 | ERBB2 | 0.28205688 |
| 138 | PRKCZ | 0.27854829 |
| 139 | ABL1 | 0.27583246 |
| 140 | CAMK2G | 0.27322966 |
| 141 | PRKCE | 0.25833021 |
| 142 | MAP3K14 | 0.24444051 |
| 143 | PAK1 | 0.22177495 |
| 144 | RPS6KA2 | 0.21293602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.55728688 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.20729842 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.16277909 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.06964743 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.06712681 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 3.04492971 |
| 7 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 2.97525911 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.80473903 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.71901636 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.65976525 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.56181234 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.46332707 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.45748324 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41005286 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.37235112 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.29333627 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.26203127 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.20347308 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.16893715 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.14041500 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.02236671 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.99143595 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99114883 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.95153323 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.92525060 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.87874757 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.83741805 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67615249 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.67569629 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63584794 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59025764 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57593314 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.54512347 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52243855 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.45696993 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44372014 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.43882753 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.36299782 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.35028927 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34372112 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33846045 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.32134862 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29916069 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28037628 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24530621 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.23701746 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23214342 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19967690 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.19680556 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.19496210 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18487397 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18387909 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18349886 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.16249921 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16131310 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 1.11121878 |
| 57 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.07427405 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03892305 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 1.02752367 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.02333364 |
| 61 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.01990552 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00687852 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99179037 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98998871 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98482128 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95057367 |
| 67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.94996701 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92777720 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92686026 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89680902 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87180718 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85273660 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85114625 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82475788 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.82460304 |
| 76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82354994 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81447105 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77774975 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77421973 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77175118 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73787580 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73381264 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.73043147 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71625516 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70587762 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.68002845 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67700917 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64758766 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64619451 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61120142 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.61001551 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59908523 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57244731 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57135002 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56810013 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53380188 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53111004 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.52808397 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50179891 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47587040 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45540378 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45102274 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43657879 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41230707 |
| 105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40083941 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38445766 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.37753395 |
| 108 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37405030 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35924670 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33968113 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31377585 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31020512 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24923844 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23212280 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.19191857 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.18651851 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.11292804 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.10838648 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.10310457 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08258374 |
| 121 | Malaria_Homo sapiens_hsa05144 | 0.04818256 |
| 122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.04036630 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.03474515 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00501086 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1170372 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.1165463 |
| 127 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.1146841 |
| 128 | Lysosome_Homo sapiens_hsa04142 | -0.1064859 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | -0.0773388 |
| 130 | Bladder cancer_Homo sapiens_hsa05219 | -0.0727628 |
| 131 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0569976 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0544250 |
| 133 | Focal adhesion_Homo sapiens_hsa04510 | -0.0491610 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0454103 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | -0.0344121 |
| 136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0211076 |

